Oral Pemphigus Vulgaris: A Case Report With Direct Immunofluorescence Study
Oral Pemphigus Vulgaris: A Case Report With Direct Immunofluorescence Study
Oral Pemphigus Vulgaris: A Case Report With Direct Immunofluorescence Study
225]
Case Report
Abstract Pemphigus vulgaris (PV) is a chronic, autoimmune, intraepidermal blistering disease of the skin and mucous
membranes. The initial clinical manifestation is frequently the development of intraoral lesions, and later,
the lesions involve the other mucous membranes and skin. The etiology of this disease still remains obscure
although the presence of autoantibodies is consistent with an autoimmune disease. These antibodies are
targeted against the adhesion proteins of keratinocytes, leading to acantholysis (disruption of spinous layer,
leading to intraepidermal clefting) and blister formation. Because only oral lesions are present initially, the
chances of misdiagnosing the disease as another condition are increased, leading to inappropriate therapy.
In this article, we report a case of PV with only oral manifestations in a 36‑year‑old male.
DOI: H o w t o c i t e t h i s a r t i c l e : K u m a r S J , N e h r u A n a n d S P,
10.4103/0973-029X.190979 Gunasekaran N, Krishnan R. Oral pemphigus vulgaris: A case report with
direct immunofluorescence study. J Oral Maxillofac Pathol 2016;20:549.
© 2016 Journal of Oral and Maxillofacial Pathology | Published by Wolters Kluwer - Medknow
[Downloaded free from http://www.jomfp.in on Tuesday, December 12, 2017, IP: 94.96.159.225]
A gingival biopsy was obtained from a perilesional site under Pemphigus is a potentially life‑threatening, autoimmune,
local anesthesia and submitted for routine histopathological intraepithelial blistering disease of the skin and mucous
examination and direct immunofluorescence (DIF) testing. membranes. There are five major categories of pemphigus: PV,
pemphigus foliaceus, PNP, drug‑induced pemphigus and IgA
The histopathological sections showed surface epithelium pemphigus. The oral mucosa is the initial site of involvement
in association with fibrous connective tissue. The surface in 70%–90% of the cases before involvement of the skin and
epithelium exhibited suprabasilar clefting and basal cell layer other mucosal sites.[3] Nasal, conjunctival, pharyngeal, laryngeal,
a b
Figure 1: (a) Intraoral view showing generalized desquamative gingivitis with ragged shallow erosions, (b) intraoral view showing irregular
erosions in the palate
Journal of Oral and Maxillofacial Pathology | Sep - Dec 2016 | Vol 20 | Issue 3
[Downloaded free from http://www.jomfp.in on Tuesday, December 12, 2017, IP: 94.96.159.225]
Figure 2: Cytological preparation showing presence of Tzanck Figure 3: Photomicrograph showing epithelium exhibiting spongiosis,
cells (PAP stain, ×200) tombstone appearance, suprabasilar split and dense inflammatory
infiltrate (H&E stain, ×100)
Journal of Oral and Maxillofacial Pathology | Sep - Dec 2016 | Vol 20 | Issue 3
[Downloaded free from http://www.jomfp.in on Tuesday, December 12, 2017, IP: 94.96.159.225]
CONCLUSION
The IgG antibodies which target Dsg‑3 are deposited at the Conflicts of interest
periphery of the epithelial cells, resulting in an appearance that There are no conflicts of interest.
has been described as resembling “chicken wire” (the type of REFERENCES
fencing material typically used to cage chickens) on viewing the
biopsy sample with DIF. The autoantibodies that are directed 1. Grando SA. Pemphigus autoimmunity: Hypotheses and realities.
against Dsg‑1 and Dsg‑3 can be identified in the circulating Autoimmunity 2012;45:7‑35.
2. Santoro FA, Stoopler ET, Werth VP. Pemphigus. Dent Clin North Am
blood serum using an indirect immunofluorescence assay that 2013;57:597‑610.
employs oldworld monkey esophagus as a target substrate. 3. Dagistan S, Goregen M, Miloglu O, Cakur B. Oral pemphigus vulgaris: A
case report with review of the literature. J Oral Sci 2008;50:359‑62.
Without proper treatment, this condition can be fatal because 4. Gambino A, Carbone M, Arduino PG, Carcieri P, Carbone L, Broccoletti R.
Conservative approach in patients with pemphigus gingival vulgaris: A pilot
of loss of the epidermal barrier function, leading to loss of study of five cases. Int J Dent 2014;2014:747506.
body fluids and secondary bacterial infection.[9] Although 5. Ohta M, Osawa S, Endo H, Kuyama K, Yamamoto H, Ito T. Pemphigus
the principal mean of treatment is systemic corticosteroid vulgaris confined to the gingiva: A case report. Int J Dent 2011;2011:207153.
6. Al‑Jassar C, Bikker H, Overduin M, Chidgey M. Mechanistic basis of
therapy, with or without so‑called “steroid‑sparing” immune desmosome‑targeted diseases. J Mol Biol 2013;425:4006‑22.
suppressants, other immune modulating drugs “intravenous” Igs, 7. Damoiseaux J. Bullous skin diseases: Classical types of autoimmune
monoclonal antibody therapy directed against B‑lymphocytes, diseases. Scientifica (Cairo) 2013;2013:457982.
have been used for effective therapy if the condition does not 8. Robinson NA, Yeo JF, Lee YS, Aw DC. Oral pemphigus vulgaris: A case
report and literature update. Ann Acad Med Singapore 2004;33 4 Suppl:63‑8.
respond to systemic corticosteroids or if the patient cannot 9. Amagai M. Autoimmune and infectious skin diseases that target desmogleins.
tolerate the side effects of this treatment. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:524‑37.
Journal of Oral and Maxillofacial Pathology | Sep - Dec 2016 | Vol 20 | Issue 3